ARCHIVES

Clinical Trials Approved In August 2002 By NCI

This article is from The Cancer Letter archive.

Vol. 25 No. 9 | September 27, 2002

Download PDF Visit The Full Archive

Related Articles

Tracors’ Prime Contract Includes $1 Million for Additional Tests

May 17, 1974

Edward Harlow Returns to NCI As Special Assistant to Varmus

January 14, 2011

Conversation with TCL:Demetri: Morcellation Worsens Outcomes In Patients with Undiagnosed Cancers

November 21, 2014

NCI Still Supporting Construction Grants Despite Big Cuts

February 20, 1981

No Interest Seen Yet In Specialized Centers For Environmental Carcinogenesis

September 26, 1975

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999